Host range expansion of Acinetobacter phage vB_Ab4_Hep4 driven by a spontaneous tail tubular mutation

Penggang He1, Feng Cao2, Qianyu Qu1

  • 1West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.

Insights

This study details a novel bacteriophage, vB_Ab4_Hep4, effective against multidrug-resistant Acinetobacter baumannii. A mutation in its tail tubular protein B expanded the phage

Area of Science:

  • Microbiology
  • Virology
  • Bacteriophage Therapy

Background:

  • Multidrug-resistant Acinetobacter baumannii (MDRAB) poses a significant threat.
  • Bacteriophages (phages) are potential alternatives to antibiotics for MDRAB infections.
  • Phage host range limitations hinder their therapeutic application.

Purpose of the Study:

  • To characterize a novel lytic phage, vB_Ab4_Hep4, targeting MDRAB.
  • To investigate the mechanism of host range expansion in a mutant phage, vB_Ab4_Hep4-M.
  • To elucidate the role of tail tubular proteins in phage host specificity.

Main Methods:

  • Isolation and characterization of lytic phage vB_Ab4_Hep4 and its mutant vB_Ab4_Hep4-M.
  • Genetic analysis to identify mutations responsible for host range expansion.
  • Expression of tail tubular protein B to confirm mutation effects.
  • Identification of bacterial capsule as the phage receptor.

Main Results:

  • A spontaneous mutant phage, vB_Ab4_Hep4-M, exhibited an expanded host range.
  • A single G-to-C mutation in the tail tubular protein B gene (Asp to His) drove host range expansion.
  • The bacterial capsule was identified as the receptor for both wild-type and mutant phages.
  • Tail tubular protein B plays a crucial role in determining A. baumannii phage host specificity.

Conclusions:

  • Phage vB_Ab4_Hep4 is a promising agent against MDRAB.
  • Tail tubular protein modification offers a strategy to broaden phage host ranges for enhanced phage therapy.
  • Understanding tail tubular-dependent specificity is key for engineering phages with improved therapeutic potential.